Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

The best-known class of medications that impact LDL-C have been the statins which have universally demonstrated reduced cardiovascular events in adequately treated patients. That means fewer heart ...

For a long time, there have been concerns that beta-blockers might cause mental health problems like depression, anxiety, and ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

A drug commonly used to treat high blood pressure, nifedipine, may pose more risks than previously thought, according to a ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...